Business Context and Reporting Period
This Form 8-K reports the results of Herbalife Ltd.'s 2017 Annual General Meeting of Shareholders held on April 27, 2017. The filing details the voting outcomes for the election of directors, executive compensation advisory votes, and the ratification of independent auditors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
Election of Directors
All 13 director nominees were elected. While the majority of votes were cast "For," significant "Against" votes were recorded for several directors, ranging from approximately 162,994 to 1,566,314 votes.
- Michael O. Johnson: 72,900,921 For; 495,740 Against
- Jeffrey T. Dunn: 73,019,387 For; 354,526 Against
- Richard P. Bermingham: 72,179,374 For; 1,194,349 Against
- Pedro Cardoso: 72,443,383 For; 953,064 Against
- Dr. Richard Carmona: 72,315,720 For; 1,080,558 Against
- Jonathan Christodoro: 72,090,408 For; 1,282,445 Against
- Keith Cozza: 72,652,372 For; 720,261 Against
- Hunter C. Gary: 71,805,634 For; 1,566,314 Against
- Jesse A. Lynn: 72,709,626 For; 663,812 Against
- Michael Montelongo: 73,188,234 For; 184,229 Against
- James L. Nelson: 73,209,604 For; 162,994 Against
- Maria Otero: 72,081,870 For; 1,290,413 Against
- John Tartol: 72,308,752 For; 1,087,668 Against
Executive Compensation (Say-on-Pay)
Shareholders approved the executive compensation proposal on an advisory basis.
- For: 64,706,766
- Against: 8,653,368
- Abstain: 133,338
Frequency of Say-on-Pay Votes
Shareholders voted to hold advisory votes on executive compensation annually (1 Year).
- 1 Year: 73,263,757
- 2 Year: 52,635
- 3 Year: 80,100
Ratification of Auditors
Shareholders ratified the independent registered public accountants for the fiscal year ending December 31, 2017.
- For: 81,863,111
- Against: 320,158
- Abstain: 133,683
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, or contingencies. The document references a definitive proxy statement filed on March 13, 2017, for greater detail on the proposals.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of "Against" votes for directors, which ranged from approximately 0.2% to 2.1% of the votes cast.
- Review the March 13, 2017, Schedule 14A proxy statement for detailed context regarding the executive compensation package and the specific reasons for the "Against" votes.
- Confirm the identity of the independent registered public accountants ratified by shareholders, as the specific firm name is not listed in this 8-K excerpt.
- Note that approximately 8.8 million broker non-votes were recorded for the director elections and compensation proposals, indicating shares held in street name where brokers lacked discretionary voting power.